To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04293393
Title Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients (CARABELA)
Acronym CARABELA
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Spanish Breast Cancer Research Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.